Vericiguat approved in the US for treatment of chronic heart failure
It has been approved for use in adults with symptomatic chronic heart failure and ejection fraction <45%, to reduce the risk of cardiovascular death and heart failure hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics.
Source:
Biospace Inc.